Involvement of dipeptidyl peptidase IV in an in vivo immune response

• Published in: Clinical and experimental immunology 1992-08, Vol.89 (2), p.192-197
• Main Authors: KUBOTA, T., FLENTKE, G. R., BACHOVCHIN, W. W., STOLLAR, B. D.
• Format: Article
• Language: English
• Subjects: accessory molecule; Animals; Antibody Formation; antibody production; Biological and medical sciences; CD 26; dipeptidyl peptidase; Dipeptidyl Peptidase 4; dipeptidyl peptidase IV; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - analysis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - antagonists & inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - physiology; Female; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Immunization; Immunobiology; Immunoglobulin G - analysis; Kinetics; Mice; Mice, Inbred BALB C; Modulation of the immune response (stimulation, suppression); protease inhibitor peptide boronic acid; serine protease; Serum Albumin, Bovine - immunology
• ISSN: 0009-9104; 1365-2249
• DOI: 10.1111/j.1365-2249.1992.tb06931.x

SUMMARY Dipeptidyl peptidase IV (DP IV) is a serine protease that selectively cleaves X‐Pro dipeptides from polypeptides and proteins. Among blood cells, this enzyme occurs preferentially on the surface of CD4+ T cells and the amount of enzyme activity increases with T cell activation. In previous work, two potent and specific peptidyl‐boronic acid inhibitors of DP IV. Ala‐boroPro and Pro‐boroPro, were synthesized and Pro‐boroPro was shown to suppress antigen‐specific proliferative responses of T cells in vitro. In this study, we tested the in vivo effects of these inhibitors. Subcutaneous injection of Ala‐boroPro or Pro‐boroPro into BALB/c mice inhibited DP IV activity in serum and spleen cell suspensions. Repeated injections of more than 10 μg of Ala‐boroPro or Pro‐boroPro at 12 h intervals maintained in vivo DP IV activity at less than 30% of the normal level. Repeated injections of the inhibitors during the primary, secondary or tertiary immune response to bovine serum albumin (BSA) reduced anti‐BSA antibody production. Without inhibitor, immunization with BSA was followed by a temporary decrease in serum DP IV activity and then by enhanced serum enzyme activity after several days. These results provide the first direct evidence that DP IV plays an important role in immune response in vivo.